Dr. Lal PathLabs Ltd
NSE:LALPATHLAB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Dr. Lal PathLabs Ltd
NSE:LALPATHLAB
|
IN |
|
P
|
Pantoro Ltd
ASX:PNR
|
AU |
|
G
|
Gentex Corp
SWB:GTX
|
US |
|
Mr Cooper Group Inc
NASDAQ:COOP
|
US |
|
Kforce Inc
NYSE:KFRC
|
US |
|
i3 Systems Inc
TSE:4495
|
JP |
|
Duke Royalty Ltd
LSE:DUKE
|
GG |
|
Kingfisher PLC
LSE:KGF
|
UK |
|
D
|
Deutsche Balaton AG
F:BBHK
|
DE |
|
B
|
Banco de Chile
SGO:CHILE
|
CL |
|
H
|
Heidelberger Druckmaschinen AG
OTC:HBGRF
|
DE |
Bankruptcy Probability
Dr. Lal PathLabs Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Dr. Lal PathLabs Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IN |
|
Dr. Lal PathLabs Ltd
NSE:LALPATHLAB
|
266.1B INR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
CVS Health Corp
NYSE:CVS
|
129.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
C
|
Cigna Group
XMUN:CGN
|
74.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Cigna Corp
NYSE:CI
|
78.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
23.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
21.2B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
22.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
21.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Guardant Health Inc
NASDAQ:GH
|
17.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
DaVita Inc
NYSE:DVA
|
13.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Brightspring Health Services Inc
NASDAQ:BTSG
|
12.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Dr. Lal PathLabs Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Dr. Lal PathLabs Ltd has total debt of 1.5B INR. This includes both short-term (0 INR) and long-term (1.5B INR) debt.
You can find a full breakdown on its Balance Sheet.
